Deloitte today announced the launch of its enhanced Digital Bank offering to further accelerate a bank's digital transformation. Based on the Salesforce Intelligent Customer Success Platform and...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today an update regarding the Company's diverse oncology portfolio, including the acceptance of a wide...

Results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (NASDAQ: HALO) of its targeted investigational therapy, PEGPH20, will...

Bayer announced today that the latest research from across its growing oncology portfolio will be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the presentation of two abstracts at the 2017 American Society of...

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and development targeted kinase medicines for patients with genomically defined diseases, today announced that new data from...

Eli Lilly and Company (NYSE: LLY) today announced that new research demonstrating advances in the Company's oncology pipeline and product portfolio will be presented at the 53rd Annual Meeting of...

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced it will present data about the company's portfolio of approved and investigational oncology medicines during the 53rd...

Amgen (NASDAQ:AMGN) today announced that new clinical data and analyses from across its oncology portfolio will be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology...

Anadarko Petroleum Corporation (NYSE: APC) today announced that Ernie Leyendecker, Anadarko Executive Vice President, International and Deepwater Exploration, will present at the 2017 UBS Global...